Avania, the leading, global medical technology CRO and advisory services partner, announces its acquisition of Anagram.

On the non-MedTech side, Nutrition and Diagnostics sales comps will ease over the next few years, driving revenue growth with ...

The medical technology sector is expected to invest billions of dollars into artificial intelligence next year.

Higher costs continue to pressure profit margins: The cost of MedTech's inputs have risen, with factors such as inflation and ...

Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that ...

SymPhysis Medical, a Galway medical technology firm focused on palliative care for late-stage cancer patients, has raised a ...

Bellevue Asset Management’s Medtech & Services Fund has successfully combined stability and diversification during the past ...

MD+DI Senior Editor Amanda Pedersen calls on investors, industry leaders, and policymakers to prevent the collapse of the medtech ecosystem as we know it.

Galway MedTech company SymPhysis Medical has secured €2.2m funding for the development of a device to address the condition ...

MedTech Innovator, a major medtech startup accelerator program, named five device developers as finalists for its grand prize ...

BioBridges said its medtech division will help companies bring products to market efficiently and effectively.